When was ImaginAb founded?

ImaginAb was founded in 2007 and raised its 1st funding round 4 years after it was founded.

Where is ImaginAb located?

ImaginAb is headquartered in Los Angeles, United States. It is registered at Inglewood, California.

How many employees does ImaginAb have?

As of Feb 28, 2026, the latest employee count at ImaginAb is 13.

Is ImaginAb a funded company?

ImaginAb is a funded company, having raised a total of $59.6M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 27, 2011.

When was the latest funding round of ImaginAb?

ImaginAb's latest funding was a $***** Series C round on Jun 03, 2021, with participation from 6 investors.

Where does ImaginAb rank among its competitors?

ImaginAb ranks 48th amongst 576 active competitors, of which 163 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Delfi Diagnostics, which secured $34.3M in Dec, 2025.

Who are the top competitors of ImaginAb?

ImaginAb's top competitors include Guardant Health, Natera and Myriad Genetics. Among them, Delfi Diagnostics secured the most recent funding round in December, 2025.

ImaginAb - 2026 Company Profile, Team, Funding & Competitors

Company Details

Immune imaging technology for cancer and autoimmune disease management. They re-engineer therapeutic antibodies against biologically important targets into small proteins optimized for diagnostic imaging with Positron Emission Tomography (PET). They aim to use their companion in-vivo diagnostics to help realize the promise of personalized medicine. This noninvasive imaging approach has been validated across several pharmaceutical-partnered immune programs and through their proprietary imaging program for prostate cancer.

Website: imaginab.com
Registered Address: Inglewood, California

Key Metrics

Founded Year

2007

Location

Los Angeles, United States

Stage

Series C

Total Funding

$59.6M in 6 rounds

Latest Funding Round

Series C, Jun 03, 2021, $*****

Investors

Novartis & 13 more

Ranked

48^th among 576 active competitors

Employee Count

13 as on Feb 28, 2026

Similar Companies

Guardant Health & 751 more

View ImaginAb's full profile

ImaginAb is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Imaginab, Inc. CIN: 264177873 , United States, Active		-	17 (As on Dec 31, 2022)	-

ImaginAb has raised a total funding of $59.6M over 6 rounds. Its first funding round was on Sep 27, 2011. Its latest funding round was a Series C round on Jun 03, 2021 for $*****. 6 investors participated in its latest round. ImaginAb has 13 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of ImaginAb:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 03, 2021	9049465	Series C	2754035	2195496	9233029	1736343
Sep 14, 2017	4523870	Series B	5528517	4530565	6002490	PICI & 4 more
Apr 12, 2016	3523274	Series B	3448735	3762071	3529307	4610753

Access funding benchmarks and valuations. Sign up today!

View details of ImaginAb's funding rounds and investors

The founders of ImaginAb are Robert E. Reiter and Anna Wu.

Here are the details of ImaginAb's key team members:

Robert E. Reiter: Co-Founder of ImaginAb.
Anna Wu: Co-Founder of ImaginAb.

View details of ImaginAb's Founder profiles and Board Members

ImaginAb's employee count trend

ImaginAb has 13 employees as of Feb 26. Here is ImaginAb's employee count trend over the years:

Uncover ImaginAb's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ImaginAb include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of ImaginAb, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Orbimed & 24 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Harmony Venture Partners ... & 17 others	77/100
3rd	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	76/100
4th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	74/100
5th	Exact Sciences 1995, Madison (United States), Public	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Bank of America & 8 others	73/100
6th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Redmile Group & 11 others	71/100
7th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
8th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 29 others	69/100
9th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	DFJ Growth, Orbimed & 18 others	68/100
10th	Foresight Diagnostics 2020, Aurora (United States), Acquired	Developer of minimally-invasive liquid biopsy test for the detection of cancer	$104M	Foresite Capital, Civilization Ventures & 6 others	66/100
48th	ImaginAb 2007, Los Angeles (United States), Series C	Immune imaging technology for cancer and autoimmune disease management	$59.6M	Cycad Group, Novartis & 12 others	51/100